Mismatch Repair-Deficient GI Tumors Respond to Anti–PD-1
Understanding mismatch repair could help ID stomach cancer patients most likely to respond to immunotherapy.
Understanding mismatch repair could help ID stomach cancer patients most likely to respond to immunotherapy.
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org